APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Virus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Japanese Encephalitis Virus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025181 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Virus Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Virus Vaccine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Virus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Virus Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Virus Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Virus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Japanese Encephalitis Virus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Japanese Encephalitis Virus Vaccine include Chengdu Institute, Liaoning Dacheng, Wuhan Institute, Valneva Austria GmbH and Research Foundation for Microbial Diseases of Osaka University, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Japanese Encephalitis Virus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Japanese Encephalitis Virus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Japanese Encephalitis Virus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Japanese Encephalitis Virus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Japanese Encephalitis Virus Vaccine Segment by Company

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

Valneva Austria GmbH

Research Foundation for Microbial Diseases of Osaka University

Japanese Encephalitis Virus Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Japanese Encephalitis Virus Vaccine Segment by Application

Public

Private

Japanese Encephalitis Virus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Virus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Virus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Virus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Japanese Encephalitis Virus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Japanese Encephalitis Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Japanese Encephalitis Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Japanese Encephalitis Virus Vaccine Industry Trends Table 2. Japanese Encephalitis Virus Vaccine Industry Drivers Table 3. Japanese Encephalitis Virus Vaccine Industry Opportunities and Challenges Table 4. Japanese Encephalitis Virus Vaccine Industry Restraints Table 5. Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers Table 9. Global Japanese Encephalitis Virus Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Japanese Encephalitis Virus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Japanese Encephalitis Virus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Japanese Encephalitis Virus Vaccine Manufacturers, Product Type & Application Table 13. Global Japanese Encephalitis Virus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Japanese Encephalitis Virus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccine Table 17. Major Manufacturers of Live Attenuated Vaccine Table 18. Global Japanese Encephalitis Virus Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Japanese Encephalitis Virus Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Japanese Encephalitis Virus Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Japanese Encephalitis Virus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Public Table 29. Major Manufacturers of Private Table 30. Global Japanese Encephalitis Virus Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Japanese Encephalitis Virus Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Japanese Encephalitis Virus Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Japanese Encephalitis Virus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Japanese Encephalitis Virus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Japanese Encephalitis Virus Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Japanese Encephalitis Virus Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Japanese Encephalitis Virus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Japanese Encephalitis Virus Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2027-2032) Table 62. Chengdu Institute Company Information Table 63. Chengdu Institute Business Overview Table 64. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio Table 66. Chengdu Institute Recent Development Table 67. Liaoning Dacheng Company Information Table 68. Liaoning Dacheng Business Overview Table 69. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio Table 71. Liaoning Dacheng Recent Development Table 72. Wuhan Institute Company Information Table 73. Wuhan Institute Business Overview Table 74. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio Table 76. Wuhan Institute Recent Development Table 77. Valneva Austria GmbH Company Information Table 78. Valneva Austria GmbH Business Overview Table 79. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio Table 81. Valneva Austria GmbH Recent Development Table 82. Research Foundation for Microbial Diseases of Osaka University Company Information Table 83. Research Foundation for Microbial Diseases of Osaka University Business Overview Table 84. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio Table 86. Research Foundation for Microbial Diseases of Osaka University Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Japanese Encephalitis Virus Vaccine Distributors List Table 90. Japanese Encephalitis Virus Vaccine Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Japanese Encephalitis Virus Vaccine Product Image Figure 2. Global Japanese Encephalitis Virus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Virus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Japanese Encephalitis Virus Vaccine Sales (2021-2032) & (k units) Figure 5. Global Japanese Encephalitis Virus Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Japanese Encephalitis Virus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccine Image Figure 9. Live Attenuated Vaccine Image Figure 10. Global Japanese Encephalitis Virus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Japanese Encephalitis Virus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Japanese Encephalitis Virus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Public Image Figure 17. Private Image Figure 18. Global Japanese Encephalitis Virus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Japanese Encephalitis Virus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Japanese Encephalitis Virus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Japanese Encephalitis Virus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Japanese Encephalitis Virus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Japanese Encephalitis Virus Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Japanese Encephalitis Virus Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Japanese Encephalitis Virus Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Japanese Encephalitis Virus Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Public
  • Private
Companies covered
  • Chengdu Institute
  • Liaoning Dacheng
  • Wuhan Institute
  • Valneva Austria GmbH
  • Research Foundation for Microbial Diseases of Osaka University

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Japanese Encephalitis Virus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Japanese Encephalitis Virus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Japanese Encephalitis Virus Vaccine Market Dynamics
  1. 2.1 Japanese Encephalitis Virus Vaccine Industry Trends
  2. 2.2 Japanese Encephalitis Virus Vaccine Industry Drivers
  3. 2.3 Japanese Encephalitis Virus Vaccine Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Virus Vaccine Industry Restraints
3 Japanese Encephalitis Virus Vaccine Market by Manufacturers
  1. 3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Japanese Encephalitis Virus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Japanese Encephalitis Virus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Japanese Encephalitis Virus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Japanese Encephalitis Virus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Japanese Encephalitis Virus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Japanese Encephalitis Virus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Japanese Encephalitis Virus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Japanese Encephalitis Virus Vaccine Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Virus Vaccine Market by Type
  1. 4.1 Japanese Encephalitis Virus Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Live Attenuated Vaccine
  4. 4.2 Global Japanese Encephalitis Virus Vaccine Sales by Type
  5. 4.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Japanese Encephalitis Virus Vaccine Revenue by Type
  9. 4.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2021-2032)
5 Japanese Encephalitis Virus Vaccine Market by Application
  1. 5.1 Japanese Encephalitis Virus Vaccine Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Japanese Encephalitis Virus Vaccine Sales by Application
  5. 5.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Japanese Encephalitis Virus Vaccine Revenue by Application
  9. 5.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Japanese Encephalitis Virus Vaccine Sales by Region
  1. 6.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Japanese Encephalitis Virus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Japanese Encephalitis Virus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Japanese Encephalitis Virus Vaccine Revenue by Region
  1. 7.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region
  2. 7.1.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Japanese Encephalitis Virus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Japanese Encephalitis Virus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu Institute
  2. 8.1.1 Chengdu Institute Company Information
  3. 8.1.2 Chengdu Institute Business Overview
  4. 8.1.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
  6. 8.1.5 Chengdu Institute Recent Developments
  7. 8.2 Liaoning Dacheng
  8. 8.2.1 Liaoning Dacheng Company Information
  9. 8.2.2 Liaoning Dacheng Business Overview
  10. 8.2.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
  12. 8.2.5 Liaoning Dacheng Recent Developments
  13. 8.3 Wuhan Institute
  14. 8.3.1 Wuhan Institute Company Information
  15. 8.3.2 Wuhan Institute Business Overview
  16. 8.3.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
  18. 8.3.5 Wuhan Institute Recent Developments
  19. 8.4 Valneva Austria GmbH
  20. 8.4.1 Valneva Austria GmbH Company Information
  21. 8.4.2 Valneva Austria GmbH Business Overview
  22. 8.4.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
  24. 8.4.5 Valneva Austria GmbH Recent Developments
  25. 8.5 Research Foundation for Microbial Diseases of Osaka University
  26. 8.5.1 Research Foundation for Microbial Diseases of Osaka University Company Information
  27. 8.5.2 Research Foundation for Microbial Diseases of Osaka University Business Overview
  28. 8.5.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
  30. 8.5.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Japanese Encephalitis Virus Vaccine Value Chain Analysis
  2. 9.1.1 Japanese Encephalitis Virus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Japanese Encephalitis Virus Vaccine Production Mode & Process
  6. 9.2 Japanese Encephalitis Virus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Japanese Encephalitis Virus Vaccine Distributors
  9. 9.2.3 Japanese Encephalitis Virus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst